Cargando…
Competing risk and heterogeneity of treatment effect in clinical trials
It has been demonstrated that patients enrolled in clinical trials frequently have a large degree of variation in their baseline risk for the outcome of interest. Thus, some have suggested that clinical trial results should routinely be stratified by outcome risk using risk models, since the summary...
Autores principales: | Kent, David M, Alsheikh-Ali, Alawi, Hayward, Rodney A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423182/ https://www.ncbi.nlm.nih.gov/pubmed/18498644 http://dx.doi.org/10.1186/1745-6215-9-30 |
Ejemplares similares
-
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
por: Kent, David M, et al.
Publicado: (2010) -
Requirements for Achieving and Maintaining Competency in the Implantation and Management of Cardiac Implantable Electrical Devices: A clinical competency statement by the Emirates Cardiac Society
por: Alkaabi, Salem, et al.
Publicado: (2013) -
Competing Risks and Multistate Models in Clinical Nephrology Research
por: Ross-Driscoll, Katie, et al.
Publicado: (2022) -
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis
por: Hayward, Rodney A, et al.
Publicado: (2006) -
Competing risks models and time-dependent covariates
por: Barnett, Adrian, et al.
Publicado: (2008)